The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly.
BACKGROUND: The nadir GH value following an oral glucose tolerance test (OGTT) and the mean GH levels obtained from a GH day curve (GHDC) are among the tools currently used for assessing therapeutic end-points in surgically treated acromegaly. The latter test, however, is cumbersome and costly. OBJ...
Main Authors: | Karavitaki, N, Fernandez, A, Fazal-Sanderson, V, Wass, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Abnormal growth hormone release in response to human pancreatic growth hormone releasing factor in acromegaly.
by: Besser, G, et al.
Published: (1983) -
Conventional Pituitary Irradiation Is Effective in Lowering Serum Growth Hormone and Insulin-Like Growth Factor-I in Patients with Acromegaly
by: Jenkins, P, et al.
Published: (2006) -
Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
by: Wass, J
Published: (1997) -
Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?
by: Fernandez, A, et al.
Published: (2008) -
Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
by: Kaltsas, G, et al.
Published: (2001)